Heterocyclic small ring propellanes, an unprecedented class of organic molecule, are now accessible via a concise, unified synthetic strategy that can be performed on multigram scale. These molecules display distinct properties compared with their established all-carbocyclic relatives, and offer direct access to valuable bridged heterocyclic small ring building blocks that are of high interest in contemporary drug design.